Search
Dyphylline
go.drugbank.com/drugs/DB00651ApprovedWithdrawnIt is typically used in the management of asthma, cardiac dyspnea, and bronchitis.
Chlormezanone
go.drugbank.com/drugs/DB01178ApprovedWithdrawnIt has been suggested for use in the treatment of muscle spasm.
Propafenone
go.drugbank.com/drugs/DB01182ApprovedInvestigationalIt also has weak beta-blocking activity. The drug is generally well tolerated.
Cefaclor
go.drugbank.com/drugs/DB00833ApprovedInvestigationalSemisynthetic, broad-spectrum antibiotic derivative of cephalexin.
Emricasan
go.drugbank.com/drugs/DB05408InvestigationalIt is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis.
Polihexanide
go.drugbank.com/drugs/DB12277ApprovedInvestigational[A1351] It is effective against a wide range of Gram-positive and Gram-negative bacteria. … [L53003] It was initially approved in August of 2024, and is the first and only approved therapy to treat patients with _Acanthamoeba_ keratitis. [L53143]
Methyl undecenoyl leucinate
go.drugbank.com/drugs/DB11272ApprovedIt is an α-MSH antagonist that inhibits melanin synthesis and tyrosinase activity and reduces expression of various melanogenic genes.
Noxytiolin
go.drugbank.com/drugs/DB13838ApprovedIt is used for THERAPEUTIC IRRIGATION of infected body cavities - bladder, peritoneum, etc. and as a spray for burns.
Palifermin
go.drugbank.com/drugs/DB00039ApprovedInvestigationalIt is 140 residues long, and is produced using E. coli. Palifermin was granted FDA approval on 15 December 2004.[L17933]